WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2022)
Top biotech stocks in 2022 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Performance Score
Market Cap
Revenue
EBITDA
Earnings
EPS
Revenue Growth Y/Y
Revenue Growth 5Y
Earnings Growth Y/Y
Earnings Growth 5Y
Earnings Date
HALO
HALOZYME THERAPEUTICS INC
$5.98B$471.57M$305.20M$434.92M$3.0842.35%28.66%156.67%N/A
EXEL
EXELIXIS INC
$6.75B$1.52B$401.79M$298.04M$0.9447.52%42.71%327.27%99.16%
INCY
INCYTE CORP
$16.40B$3.32B$694.45M$945.01M$4.2722.05%20.51%177.27%N/A
CPRX
CATALYST PHARMACEUTICALS INC
$1.09B$153.72M$60.73M$45.06M$0.4427.95%N/A-36.23%N/A
UTHR
UNITED THERAPEUTICS CORP
$9.98B$1.79B$874.60M$630.80M$13.9712.45%1.85%32.29%8.76%
MRNA
MODERNA INC
$66.95B$23.00B$15.97B$14.06B$34.97227.61%N/A302.42%N/A
XOMA
XOMA CORP
$220.66M$40.98M$18.72M$9.54M$0.8639.30%27.19%43.33%N/A
HRMY
HARMONY BIOSCIENCES HOLDINGS INC
$3.00B$364.29M$104.97M$58.11M$0.9854.76%N/A-48.69%N/A
SESN
SESEN BIO INC
$140.82M$20.00M$35.40M$47.80M$0.2512.49%-7.73%N/A2.59%
CORT
CORCEPT THERAPEUTICS INC
$3.01B$392.03M$134.12M$112.72M$1.0214.26%29.25%21.43%37.18%
VRTX
VERTEX PHARMACEUTICALS INC
$76.64B$8.35B$4.13B$3.19B$12.4724.94%31.40%62.37%64.03%
GMAB
GENMAB A
$23.09B$1.27B$582.54M$334.79M$0.51-22.62%N/A-60.71%N/A
AVIR
ATEA PHARMACEUTICALS INC
$706.03M$224.99M$25.91M$15.53M$0.1828.56%N/A-85.83%N/A
LJPC
LA JOLLA PHARMACEUTICAL CO
$158.45M$52.01M$17.40M$5.24M$0.20-13.27%167.18%N/AN/A
REGN
REGENERON PHARMACEUTICALS INC
$67.82B$14.23B$6.70B$5.69B$53.3714.88%22.13%-9.37%37.25%
VNDA
VANDA PHARMACEUTICALS INC
$580.89M$262.70M$18.36M$10.99M$0.211.61%10.96%-64.41%N/A
CDMO
AVID BIOSERVICES INC
$1.09B$119.60M$19.82M$127.67M$2.0824.75%15.72%3,366.67%N/A2022-09-06
SIGA
SIGA TECHNOLOGIES INC
$1.66B$147.41M$92.53M$71.77M$0.9654.42%47.26%71.43%N/A
TECH
BIO-TECHNE CORP
$14.17B$1.08B$352.93M$225.49M$5.7526.96%14.74%20.04%23.64%
GNFT
GENFIT SA
$242.10M$93.02M$86.24M$73.11M$1.64927.89%N/AN/AN/A
AUPH
AURINIA PHARMACEUTICALS INC
$1.15B$87.89M-$152.92M-$156.72M-$1.1652.60%191.16%N/AN/A
CLSD
CLEARSIDE BIOMEDICAL INC
$96.84M$29.89M$262.00k$83.00k$0.01680.16%356.96%N/AN/A
IMTX
IMMATICS NV
$782.19M$138.58M$24.66M$16.10M$0.27284.86%N/AN/AN/A
BNTX
BIONTECH SE
$38.21B$21.62B$17.28B$11.99B$78.89141.15%N/A348.54%N/A
ATNM
ACTINIUM PHARMACEUTICALS INC
$128.67M$1.46M-$24.05M-$24.58M-$1.14135.05%N/AN/AN/A
UPC
UNIVERSE PHARMACEUTICALS INC
$14.36M$47.98M$14.23M$11.32M$0.7056.27%N/A48.94%N/A
SLGL
SOL-GEL TECHNOLOGIES LTD
$145.07M$33.16M$10.32M$9.59M$0.42471.60%N/AN/AN/A
ALEC
ALECTOR INC
$1.05B$300.73M$46.62M$36.26M$0.451,303.00%N/AN/AN/A
LPCN
LIPOCINE INC
$64.17M$16.64M$3.53M$3.42M$0.04N/AN/AN/AN/A
CLNN
CLENE INC
$215.07M$540.00k$18.51M$16.66M$0.2854.73%N/AN/AN/A
DVAX
DYNAVAX TECHNOLOGIES CORP
$2.15B$673.80M$248.32M$228.39M$1.86298.54%144.53%N/AN/A
CARA
CARA THERAPEUTICS INC
$634.50M$48.89M-$64.74M-$66.35M-$1.26-60.35%121.79%N/AN/A
LOGC
LOGICBIO THERAPEUTICS INC
$19.12M$7.77M-$33.67M-$36.41M-$1.12168.31%N/AN/AN/A
NBIX
NEUROCRINE BIOSCIENCES INC
$10.30B$1.30B$45.80M$12.20M$0.1325.67%189.88%-96.68%N/A
OPNT
OPIANT PHARMACEUTICALS INC
$63.69M$45.87M-$3.68M-$6.33M-$1.1144.56%N/AN/AN/A
SNDX
SYNDAX PHARMACEUTICALS INC
$1.36B$138.95M$3.27M$818.00k$0.219,065.63%157.81%N/AN/A
NVO
NOVO NORDISK A S
$241.63B$21.48B$10.39B$6.90B$3.036.26%4.68%1.53%5.59%
HSTO
HISTOGEN INC
$5.64M$4.36M-$11.24M-$11.35M-$5.40188.10%-10.99%N/AN/A2022-08-11
RPRX
ROYALTY PHARMA PLC
$26.52B$2.26B$651.43M$466.10M$1.060.94%N/A-57.43%N/A
LUMO
LUMOS PHARMA INC
$67.79M$341.00k-$30.15M-$29.52M-$3.49131.97%-59.88%N/AN/A
IMGN
IMMUNOGEN INC
$1.16B$89.44M-$158.82M-$160.68M-$0.69-34.54%0.09%N/AN/A
SELB
SELECTA BIOSCIENCES INC
$390.95M$127.64M$53.13M$31.72M$0.25169.79%98.51%N/AN/A
VIR
VIR BIOTECHNOLOGY INC
$3.82B$2.33B$1.65B$1.22B$9.303,102.56%N/AN/AN/A
ABCM
ABCAM PLC
$3.36B$409.61M$2.60M$5.71M$0.0314.00%N/AN/AN/A
LPTX
LEAP THERAPEUTICS INC
$96.27M$1.13M-$41.87M-$41.83M-$0.43-25.00%N/AN/AN/A2022-08-11
MRUS
MERUS NV
$1.22B$52.72M-$52.56M-$53.88M-$1.2937.59%35.00%N/AN/A
RPTX
REPARE THERAPEUTICS INC
$500.32M$8.24M-$129.10M-$132.03M-$3.281,321.03%N/AN/AN/A2022-08-10
SEER
SEER INC
$641.28M$9.87M-$73.86M-$78.39M-$1.271,723.84%N/AN/AN/A
ZLAB
ZAI LAB LTD
$4.43B$170.93M-$540.09M-$553.96M-$5.91180.94%N/AN/AN/A
STTK
SHATTUCK LABS INC
$155.11M$27.75M-$56.00M-$57.69M-$1.36200.68%N/AN/AN/A
CSBR
CHAMPIONS ONCOLOGY INC
$125.35M$49.11M$2.21M$548.00k$0.0419.66%26.09%33.33%N/A2022-09-12
FBIO
FORTRESS BIOTECH INC
$119.23M$81.13M-$51.22M-$71.64M-$2.2683.27%6.04%N/AN/A2022-08-15
ADAG
ADAGENE INC
$62.89M$10.18M-$69.99M-$73.21M-$1.831,351.71%N/AN/AN/A
AVEO
AVEO PHARMACEUTICALS INC
$265.15M$79.04M-$31.41M-$36.14M-$1.03466.13%81.60%N/AN/A
ITCI
INTRA-CELLULAR THERAPIES INC
$5.31B$102.92M-$302.92M-$303.50M-$3.64173.67%199.65%N/AN/A
ALBO
ALBIREO PHARMA INC
$488.23M$45.45M-$19.53M-$32.73M-$1.70420.86%32.23%N/AN/A2022-08-15
BYSI
BEYONDSPRING INC
$57.22M$1.35M-$60.46M-$64.18M-$1.64650.56%N/AN/AN/A
ADMA
ADMA BIOLOGICS INC
$398.59M$94.00M-$59.17M-$78.28M-$0.4895.55%53.12%N/AN/A2022-08-10
NBRV
NABRIVA THERAPEUTICS PLC
$122.44M$35.33M-$45.28M-$46.61M-$0.08143.30%42.53%N/AN/A
NTRB
NUTRIBAND INC
$37.88M$1.47M-$6.13M-$6.75M-$0.9816.60%N/AN/AN/A2022-09-01
EYEN
EYENOVIA INC
$55.72M$12.00M-$13.97M-$14.77M-$0.52200.00%N/AN/AN/A2022-08-10
SYBX
SYNLOGIC INC
$69.97M$2.00M-$56.46M-$61.29M-$0.97348.99%43.10%N/AN/A2022-08-11
LMNL
LIMINAL BIOSCIENCES INC
$15.52M$338.28k$24.83M$17.04M$0.59-41.79%N/AN/AN/A2022-08-15
IVA
INVENTIVA SA
$204.37M$9.45M-$53.25M-$55.15M-$1.4150.51%N/AN/AN/A
QURE
UNIQURE NV
$888.79M$61.97M-$98.29M-$114.06M-$2.46-87.61%20.28%N/AN/A
FNCH
FINCH THERAPEUTICS GROUP INC
$117.47M$15.33M-$65.49M-$68.75M-$1.4661.74%N/AN/AN/A
MIRM
MIRUM PHARMACEUTICALS INC
$900.35M$38.51M-$40.78M-$53.09M-$1.65250.13%N/AN/AN/A
ORGS
ORGENESIS INC
$41.20M$33.33M$17.09M$13.83M$0.89119.78%37.71%-73.35%N/A
LEXX
LEXARIA BIOSCIENCE CORP
$16.60M$175.27k-$7.01M-$6.98M-$1.25-76.81%24.06%N/AN/A
XENE
XENON PHARMACEUTICALS INC
$2.09B$22.85M-$82.03M-$81.12M-$1.70-22.42%79.73%N/AN/A
DBVT
DBV TECHNOLOGIES SA
$519.02M$8.33M-$76.34M-$77.45M-$0.6789.36%N/AN/AN/A
EDIT
EDITAS MEDICINE INC
$1.24B$31.80M-$181.71M-$184.49M-$2.70-60.81%41.33%N/AN/A
ENTX
ENTERA BIO LTD
$51.27M$482.00k-$6.61M-$6.48M-$0.980.42%N/AN/AN/A2022-08-15
GANX
GAIN THERAPEUTICS INC
$47.41M$210.66k-$16.19M-$16.24M-$1.3691.03%N/AN/AN/A
BGNE
BEIGENE LTD
$20.54B$1.07B-$1.96B-$2.01B-$1.5812.84%N/AN/AN/A
VCNX
VACCINEX INC
$45.22M$50.00k-$19.77M-$20.40M-$0.65-96.61%N/AN/AN/A2022-08-15
EIGR
EIGER BIOPHARMACEUTICALS INC
$382.07M$13.16M-$84.04M-$88.52M-$2.44129.20%N/AN/AN/A
PRQR
PROQR THERAPEUTICS NV
$59.97M$4.14M-$59.42M-$63.87M-$0.91174.11%25.36%N/AN/A
MRVI
MARAVAI LIFESCIENCES HOLDINGS INC
$6.48B$920.28M$380.04M$247.82M$1.9466.66%N/A-75.81%N/A
CLGN
COLLPLANT BIOTECHNOLOGIES LTD
$98.56M$1.21M-$13.10M-$13.75M-$1.34-93.97%N/AN/AN/A2022-08-17
BMRN
BIOMARIN PHARMACEUTICAL INC
$17.75B$1.91B$177.12M$54.07M$0.29-0.26%9.74%-93.72%N/A
INMB
INMUNE BIO INC
$166.90M$356.00k-$32.87M-$32.87M-$1.872,273.33%N/AN/AN/A
BLCM
BELLICUM PHARMACEUTICALS INC
$11.54M$6.20M-$5.94M-$6.47M-$0.021,140.00%71.00%N/AN/A2022-08-10
CGEN
COMPUGEN LTD
$124.74M$6.00M-$33.20M-$33.66M-$0.40200.00%117.60%N/AN/A
HCM
HUTCHMED (CHINA) LTD
$2.36B$400.81M-$248.68M-$255.11M-$1.5043.88%10.97%N/AN/A
RGNX
REGENXBIO INC
$1.47B$484.30M$140.95M$90.72M$2.20200.29%122.72%N/AN/A
RCUS
ARCUS BIOSCIENCES INC
$1.82B$408.72M$80.87M$66.77M$1.04339.78%N/AN/AN/A
ITOS
ITEOS THERAPEUTICS INC
$929.74M$497.30M$390.19M$297.64M$8.45N/AN/AN/AN/A2022-08-10
JANX
JANUX THERAPEUTICS INC
$518.70M$4.85M-$43.61M-$43.80M-$1.491,175.26%N/AN/AN/A
SPRC
SCISPARC LTD
$3.86M$0.00-$1.74M-$1.75M$0.86N/AN/A2,751.61%N/A
MESO
MESOBLAST LTD
$401.65M$9.98M-$80.41M-$91.95M-$0.7162.01%-19.05%N/AN/A
ICCC
IMMUCELL CORP
$69.07M$21.14M$3.57M$1.10M$0.1545.37%15.91%N/A2.90%2022-08-11
ROIV
ROIVANT SCIENCES LTD
$2.79B$46.06M-$555.63M-$556.18M$0.02N/AN/AN/AN/A
XNCR
XENCOR INC
$1.74B$289.37M$30.99M$22.49M$0.4061.99%41.09%0.00%N/A
FSTX
F-STAR THERAPEUTICS INC
$140.78M$20.80M-$32.71M-$33.79M-$1.5462.28%210.56%N/AN/A2022-08-10
CTXR
CITIUS PHARMACEUTICALS INC
$138.82M$0.00-$27.40M-$29.02M-$0.19N/AN/AN/AN/A2022-08-10
ONTX
ONCONOVA THERAPEUTICS INC
$26.96M$226.00k-$15.56M-$15.57M-$0.85-3.83%-44.47%N/AN/A2022-08-11
HUMA
HUMACYTE INC
$354.34M$1.34M-$12.51M-$26.01M$1.36-3.59%N/AN/AN/A
ATRA
ATARA BIOTHERAPEUTICS INC
$442.56M$71.81M-$235.95M-$247.65M-$2.55867.54%N/AN/AN/A
DYAI
DYADIC INTERNATIONAL INC
$74.90M$2.59M-$12.27M-$12.27M-$0.4448.35%N/AN/AN/A2022-08-10

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Aug 2022?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Halozyme Therapeutics (NASDAQ:HALO)


Halozyme Therapeutics (NASDAQ:HALO) is the top biotech stock with a Zen Score of 75, which is 45 points higher than the biotech industry average of 30. It passed 25 out of 33 due diligence checks and has strong fundamentals. Halozyme Therapeutics has seen its stock return 7.15% over the past year, overperforming other biotech stocks by 45 percentage points.

Halozyme Therapeutics has an average 1 year price target of $53.00, an upside of 22.32% from Halozyme Therapeutics's current stock price of $43.33.

Halozyme Therapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Halozyme Therapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Exelixis (NASDAQ:EXEL)


Exelixis (NASDAQ:EXEL) is the second best biotech stock with a Zen Score of 75, which is 45 points higher than the biotech industry average of 30. It passed 24 out of 33 due diligence checks and has strong fundamentals. Exelixis has seen its stock return 20% over the past year, overperforming other biotech stocks by 58 percentage points.

Exelixis has an average 1 year price target of $31.13, an upside of 47.79% from Exelixis's current stock price of $21.06.

Exelixis stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Exelixis, 37.5% have issued a Strong Buy rating, 50% have issued a Buy, 12.5% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the third best biotech stock with a Zen Score of 74, which is 44 points higher than the biotech industry average of 30. It passed 24 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -2.1% over the past year, overperforming other biotech stocks by 36 percentage points.

Incyte has an average 1 year price target of $84.13, an upside of 14.1% from Incyte's current stock price of $73.73.

Incyte stock has a consensus Hold recommendation according to Wall Street analysts. Of the 9 analysts covering Incyte, 0% have issued a Strong Buy rating, 33.33% have issued a Buy, 55.56% have issued a hold, while 11.11% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 1.97%, which is 1 percentage points higher than the biotech industry average of 1.37%.

Siga Technologies's dividend payout ratio of 46.9% indicates that its dividend yield is sustainable for the long-term.

2. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.65%, which is the same as the biotech industry average of 1.37%.

Royalty Pharma's dividend payout ratio of 67.9% indicates that its dividend yield is sustainable for the long-term.

3. Novo Nordisk A S (NYSE:NVO)


Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.52%, which is the same as the biotech industry average of 1.37%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% seven times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 52.6% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -2.14% in the last day, and up 9.38% over the last week. Cormedix was the among the top losers in the biotechnology industry, dropping -57.45% yesterday.

CorMedix shares are trading lower after the company announced it received a second Complete Response Letter from the FDA stating that the DefenCath NDA cannot be approved until certain deficiencies are resolved to the satisfaction of the FDA.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Moderna (NASDAQ:MRNA)


Moderna (NASDAQ:MRNA) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Moderna has a valuation score of 86, which is 52 points higher than the biotech industry average of 34. It passed 6 out of 7 valuation due diligence checks.

Moderna's stock has dropped -64.67% in the past year. It has underperformed other stocks in the biotech industry by -27 percentage points.

2. Sesen Bio (NASDAQ:SESN)


Sesen Bio (NASDAQ:SESN) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Sesen Bio has a valuation score of 86, which is 52 points higher than the biotech industry average of 34. It passed 6 out of 7 valuation due diligence checks.

Sesen Bio's stock has dropped -81.99% in the past year. It has underperformed other stocks in the biotech industry by -44 percentage points.

3. Orgenesis (NASDAQ:ORGS)


Orgenesis (NASDAQ:ORGS) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Orgenesis has a valuation score of 86, which is 52 points higher than the biotech industry average of 34. It passed 6 out of 7 valuation due diligence checks.

Orgenesis's stock has dropped -67.89% in the past year. It has underperformed other stocks in the biotech industry by -30 percentage points.

Are biotech stocks a good buy now?

49.65% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 92.14% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -5.67x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.